XOMA - NASDAQ

XOMA Royalty Corp.

XOMA·NASDAQ

$41.92

+0.55%

HealthcareBiotechnology

XOMA Royalty Corp. operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$525.72M

EPS1.5300

P/E Ratio27.40

Earnings Date07/30/2026

xoma

Long Term Debt

Last Annual Value

116.56M

3-Year CAGR

5-Year CAGR

56%

10-Year CAGR

11%

Adjust for Inflation

XOMA Royalty Corp. Competitors Analysis of Long Term Debt

XOMA · NASDAQ

Company	Long Term Debt	CAGR 3Y	CAGR 5Y	CAGR 10Y
XOMA Royalty Corp. NASDAQ:XOMA	116.56M	-0.6%	N/A	16.5%
Quantum-Si incorporated NASDAQ:QSI	2.32M	N/A	N/A	N/A
Korro Bio, Inc. NASDAQ:KRRO	0.00	N/A	N/A	N/A
4D Molecular Therapeutics, Inc. NASDAQ:FDMT	15.82M	N/A	N/A	N/A
MBX Biosciences, Inc. Common Stock NASDAQ:MBX	424.00K	N/A	N/A	N/A
PureTech Health plc NASDAQ:PRTC	0.00	N/A	N/A	N/A
RAPT Therapeutics, Inc. NASDAQ:RAPT	0.00	N/A	N/A	N/A
Lineage Cell Therapeutics, Inc. AMEX:LCTX	0.00	N/A	N/A	N/A
Rocket Pharmaceuticals, Inc. NASDAQ:RCKT	0.00	N/A	N/A	N/A
Aura Biosciences, Inc. NASDAQ:AURA	14.13M	N/A	N/A	N/A
Galectin Therapeutics Inc. NASDAQ:GALT	133.74M	23.1%	35.7%	N/A

XOMA Royalty Corp. Fair Value Envelope

XOMA · NASDAQ

Our analysis suggests that XOMA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $41.92, this represents a potential HIDDEN relative to our calculated worth for XOMA Royalty Corp..

HIDDEN

Intrinsic Value

Current Price: $41.92

Related Guides

Blog Categories

Continue your XOMA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.